On Tuesday, Precigen Inc (NASDAQ: PGEN) opened higher 6.59% from the last session, before settling in for the closing price of $1.67. Price fluctuations for PGEN have ranged from $0.65 to $2.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -15.17% annually for the last half of the decade. Company’s average yearly earnings per share was noted -14.53% at the time writing. With a float of $162.74 million, this company’s outstanding shares have now reached $292.87 million.
In an organization with 202 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -63.15%, operating margin of -3277.95%, and the pretax margin is -3573.1%.
Precigen Inc (PGEN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Precigen Inc is 44.43%, while institutional ownership is 26.15%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.53% per share during the next fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Check out the current performance indicators for Precigen Inc (PGEN). In the past quarter, the stock posted a quick ratio of 1.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 131.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 2.0 million. That was inferior than the volume of 2.21 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.92%. Additionally, its Average True Range was 0.19.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 74.32%, which indicates a significant increase from 35.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 78.22% in the past 14 days, which was lower than the 91.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3700, while its 200-day Moving Average is $1.2193. However, in the short run, Precigen Inc’s stock first resistance to watch stands at $1.8633. Second resistance stands at $1.9467. The third major resistance level sits at $2.0933. If the price goes on to break the first support level at $1.6333, it is likely to go to the next support level at $1.4867. The third support level lies at $1.4033 if the price breaches the second support level.
Precigen Inc (NASDAQ: PGEN) Key Stats
There are currently 292,869K shares outstanding in the company with a market cap of 521.31 million. Presently, the company’s annual sales total 6,230 K according to its annual income of -95,900 K. Last quarter, the company’s sales amounted to 950 K and its income totaled -23,980 K.
